[{"address1": "Clarence Thomas Building", "address2": "P.O. Box 4649 Road Town", "city": "Tortola", "zip": "VG1110", "country": "British Virgin Islands", "phone": "203 221 7378", "website": "https://www.portagebiotech.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline includes PORT-2 for treatment of refractory NSCLC, melanoma, and refractory melanoma that is in phase I and phase II clinical trials; PORT-3, for treatment of solid tumors, which is in phase I clinical trials; PORT-6, an A2AR inhibitor to treat A2A & A2B high solid tumors that is in phase Ia clinical trials; PORT-7, an A2AR inhibitor to treat A2A & A2B high solid tumors that is in phase Ib clinical trials; PORT-1, an intratumoral amphiphilic solutions for treatment of advanced soft tissue sarcoma, which is in phase 3 clinical trials; PORT-4, a nanolipogel co-formulations to treat of solid tumors that is in preclinical trials; and PORT-5, a VLP-STING to treat of solid tumors that is in preclinical trials. The company is based in Tortola, British Virgin Islands.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Ian B. Walters M.B.A., M.D.", "age": 55, "title": "CEO & Chairman of Board", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 717885, "exercisedValue": 0, "unexercisedValue": 695213}, {"maxAge": 1, "name": "Mr. Allan J. Lee Shaw CPA", "age": 59, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 518205, "exercisedValue": 0, "unexercisedValue": 311452}, {"maxAge": 1, "name": "Dr. Robert A. Kramer Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "totalPay": 185891, "exercisedValue": 0, "unexercisedValue": 128769}, {"maxAge": 1, "name": "Mr. Brian  Wiley", "age": 55, "title": "Chief Business Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 155422, "exercisedValue": 0, "unexercisedValue": 130948}, {"maxAge": 1, "name": "Mr. Justin  Fairchild", "title": "Vice President of Development", "fiscalYear": 2024, "totalPay": 325301, "exercisedValue": 0, "unexercisedValue": 67798}, {"maxAge": 1, "name": "Mr. Joseph  Ciavarella", "title": "Chief Accounting Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "maxAge": 86400, "priceHint": 4, "previousClose": 3.5, "open": 3.27, "dayLow": 2.75, "dayHigh": 3.573, "regularMarketPreviousClose": 3.5, "regularMarketOpen": 3.27, "regularMarketDayLow": 2.75, "regularMarketDayHigh": 3.573, "forwardPE": -5.2884617, "volume": 231688, "regularMarketVolume": 231688, "averageVolume": 91185, "averageVolume10days": 290400, "averageDailyVolume10Day": 290400, "bid": 2.86, "ask": 3.0, "bidSize": 2600, "askSize": 1200, "marketCap": 2883677, "fiftyTwoWeekLow": 2.1, "fiftyTwoWeekHigh": 61.98, "fiftyDayAverage": 3.9466, "twoHundredDayAverage": 13.13185, "currency": "USD", "enterpriseValue": -2792000, "floatShares": 566612, "sharesOutstanding": 1048610, "sharesShort": 3029, "sharesShortPriorMonth": 699, "sharesShortPreviousMonthDate": 1719532800, "dateShortInterest": 1722384000, "sharesPercentSharesOut": 0.0031, "heldPercentInsiders": 7.2805, "heldPercentInstitutions": 1.8702099, "shortRatio": 0.04, "shortPercentOfFloat": 0.0047, "bookValue": 3.838, "priceToBook": 0.716519, "lastFiscalYearEnd": 1711843200, "nextFiscalYearEnd": 1743379200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -75339000, "trailingEps": -170.4, "forwardEps": -0.52, "enterpriseToEbitda": 0.153, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "PRTG", "underlyingSymbol": "PRTG", "shortName": "Portage Biotech Inc.", "longName": "Portage Biotech Inc.", "firstTradeDateEpochUtc": 1009981800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "c85b618a-5b14-3e35-9d8d-d4e5ddb2236b", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.75, "recommendationMean": 3.0, "recommendationKey": "hold", "totalCash": 5028000, "totalCashPerShare": 4.798, "ebitda": -18199000, "totalDebt": 47000, "quickRatio": 1.746, "currentRatio": 2.673, "debtToEquity": 1.412, "returnOnAssets": -0.21341999, "returnOnEquity": -1.9151, "freeCashflow": -9936125, "operatingCashflow": -14297000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-08-19"}]